Parker Waichman LLP Headlines by Topic
Boston Scientific Taxus Stent
Recall for Boston Scientific Implantable Defibrillators
Mar 16, 2010
| Parker Waichman LLP
A massive recall is being issued for seven brands of Boston Scientific implantable heart defibrillators. The recall is being issued because...
Lawsuits Allege Medtronic, Other Firms Illegally Marketed Surgical Ablation Products
Jul 16, 2009
| Parker Waichman LLP
Medtronic Inc., St. Jude Medical Inc., AtriCure Inc. and Boston Scientific Corp. all allegedly paid kickbacks to doctors in order to convince them to...
FDA Approves Boston Scientific Stent Despite Earlier Problems
Oct 13, 2008
| Parker Waichman LLP
Late last week, Boston Scientific Corporation announced that U.S. health regulators approved the next-generation version of its widely used Taxus...
Surgery Deemed More Effective Than Boston Scientifics’ Taxus Stent
Sep 2, 2008
| Parker Waichman LLP
Doctors are now reporting that Boston Scientific Corporation’s Taxus stent did not fare as well as bypass surgery in improving medical outcomes...
Efficacy of heart stents called into question
Mar 27, 2007
| Financial Times
A seven-year US study has called into question whether doctors are overusing heart stents, the blockbuster tiny wire mesh tubes used to prop open...
Angioplasty no better than drugs, study says
Mar 27, 2007
| Boston Globe
A large and long-awaited study finds that angioplasty works no better than medication at preventing heart attacks or death, a finding that could slow...
Study: Heart Stents Often Not Worth the Risk or Cost
Mar 27, 2007
| NewsInferno.com
A highly anticipated new study has called into question the long-term effectiveness of stents in the treatment of stable coronary artery disease....
Heart Stents No Better Than Treating Stable Heart Patients With Medication, Study Shows
Mar 26, 2007
| Washington Post
The study of more than 2,000 patients found that those who underwent the expensive procedure, known as angioplasty, in non-emergency situations were...
Heart stent makers brace for new heart study
Mar 26, 2007
| AP
Wall Street analysts and many doctors expect another potential setback for makers of stents when results of a blockbuster study Tuesday will answer...
Analysis: Stents' heart value in doubt
Mar 26, 2007
| UPI
Doctors said Monday that angioplasty plus stenting a common, expensive heart procedure plus the best medical treatment failed to reduce the risk of...
